US2015094336A1PendingUtilityA1

Methods for treating gliomas with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione

Assignee: CELGENE CORPPriority: May 17, 2002Filed: Dec 9, 2014Published: Apr 2, 2015
Est. expiryMay 17, 2022(expired)· nominal 20-yr term from priority
A61P 37/02A61P 7/06A61P 9/10A61P 43/00A61P 37/06A61P 9/00A61P 35/04A61P 29/00A61P 33/02A61P 31/04A61P 31/12A61P 35/00A61P 27/14A61P 27/02A61P 27/06A61P 31/10A61P 31/00A61K 9/0053A61K 31/445A61K 9/4858A61K 35/12A61K 39/3955A61K 31/573A61K 31/40A61K 31/198A61K 31/475A61K 31/425A61P 1/02A61K 2300/00A61K 45/06A61P 19/08A61K 31/00A61K 31/4035A61K 31/4439A61K 31/7048A61K 31/454A61P 17/00A61K 9/4866A61P 17/02A61K 31/515A61P 19/02A61K 31/704A61K 31/675C07D 401/00Y02A50/30
73
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods of treating, preventing and/or managing cancer as well as and diseases and disorders associated with, or characterized by, undesired angiogenesis are disclosed. Specific methods encompass the administration of an immunomodulatory compound alone or in combination with a second active ingredient. The invention further relates to methods of reducing or avoiding adverse side effects associated with chemotherapy, radiation therapy, hormonal therapy, biological therapy or immunotherapy which comprise the administration of an immunomodulatory compound. Pharmaceutical compositions, single unit dosage forms, and kits suitable for use in methods of the invention are also disclosed.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method of treating, managing or preventing a specific cancer, which comprises administering to a patient in need of such treatment, management or prevention a therapeutically or prophylactically effective amount of an immunomodulatory compound, or a pharmaceutically acceptable salt, solvate, hydrate, stereoisomer, clathrate, or prodrug thereof. 
     
     
         2 - 21 . (canceled)

Join the waitlist — get patent alerts

Track US2015094336A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.